For years the Dutch have been courting Russian business. Now they want their dead back
Traffic to Chipotle Mexican Grill increased in the second quarter, despite price increases
It remains to be seen whether any religious groups with federal contracts will argue that they should be allowed to discriminate if they want to
What Netflix lovingly refers to as "Content" puts the company far ahead of Amazon and Hulu in the race to become a real HBO competitor
A months-long public-relations debacle is taking a heavy toll on the operators of dark pools
The furniture manufacturer of midcentury classics acquires its largest retail outlet
That an accordion-playing parodist has become one of the most enduring musical acts of our time is, well, a little weird
A new report shows young college-educated professionals will wait a long time to see the financial rewards of their degree.
Profiled companies pay the recruiting service, but job-seekers don't
Kathy Callender, 67
After 12 years in business, PharmaJet may finally be able to sell its first product: a simple, needle-free injection device with a disposable syringe designed for use in third-world countries that can help prevent injury and the spread of disease. The company just received clearance from the Food & Drug Administration to use the tool for vaccines and injectable medicines. The 25-person company has not recorded any revenues to date, but plans to start selling its devices this year. So far, it has been developing the product with help from angel investors. "I want to make a difference in global world health," says Callender, a 35-year veteran of the health-care industry. "Before starting the firm, my husband and I would do medical mission work in the developing world, and it really just showed us how much need there is out there. I want to get needles out of the garbage and prevent injury to workers and patients."